Mévélec MN - Search Results

1

The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant properties.

Hedhli D, Moiré N, Akbar H, Laurent F, Héraut B, Dimier-Poisson I, Mévélec MN. Hedhli D, et al. Among authors: mevelec mn. Med Microbiol Immunol. 2016 Aug;205(4):345-52. doi: 10.1007/s00430-016-0452-3. Epub 2016 Mar 2. Med Microbiol Immunol. 2016. PMID: 26935827

2

Amplification of the secretory IgA response to Toxoplasma gondii using cholera toxin.

Bourguin I, Chardes T, Mevelec MN, Woodman JP, Bout D. Bourguin I, et al. Among authors: mevelec mn. FEMS Microbiol Lett. 1991 Jul 1;65(3):265-71. doi: 10.1016/0378-1097(91)90225-y. FEMS Microbiol Lett. 1991. PMID: 1916225

3

Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.

Chardès T, Velge-Roussel F, Mevelec P, Mevelec MN, Buzoni-Gatel D, Bout D. Chardès T, et al. Among authors: mevelec mn, mevelec p. Immunology. 1993 Mar;78(3):421-9. Immunology. 1993. PMID: 8478024 Free PMC article.

4

Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses.

Sagodira S, Iochmann S, Mevelec MN, Dimier-Poisson I, Bout D. Sagodira S, et al. Among authors: mevelec mn. Parasite Immunol. 1999 Oct;21(10):507-16. doi: 10.1046/j.1365-3024.1999.00247.x. Parasite Immunol. 1999. PMID: 10587377 Free article.

5

Prospects for a human Toxoplasma vaccine.

Bout DT, Mevelec MN, Velge-Roussel F, Dimier-Poisson I, Lebrun M. Bout DT, et al. Among authors: mevelec mn. Curr Drug Targets Immune Endocr Metabol Disord. 2002 Oct;2(3):227-34. doi: 10.2174/1568008023340488. Curr Drug Targets Immune Endocr Metabol Disord. 2002. PMID: 12476487 Review.

6

Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells.

Dimier-Poisson I, Aline F, Mévélec MN, Beauvillain C, Buzoni-Gatel D, Bout D. Dimier-Poisson I, et al. Among authors: mevelec mn. Infect Immun. 2003 Sep;71(9):5254-65. doi: 10.1128/IAI.71.9.5254-5265.2003. Infect Immun. 2003. PMID: 12933872 Free PMC article.

7

A novel CD4-CD8alpha+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis.

Ruiz S, Beauvillain C, Mévélec MN, Roingeard P, Breton P, Bout D, Dimier-Poisson I. Ruiz S, et al. Among authors: mevelec mn. Cell Microbiol. 2005 Nov;7(11):1659-71. doi: 10.1111/j.1462-5822.2005.00583.x. Cell Microbiol. 2005. PMID: 16207252

8

Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA.

Dimier-Poisson I, Aline F, Bout D, Mévélec MN. Dimier-Poisson I, et al. Among authors: mevelec mn. Vaccine. 2006 Mar 6;24(10):1705-9. doi: 10.1016/j.vaccine.2005.09.053. Epub 2005 Oct 10. Vaccine. 2006. PMID: 16256251

9

Mic1-3 knockout of Toxoplasma gondii is a successful vaccine against chronic and congenital toxoplasmosis in mice.

Ismael AB, Dimier-Poisson I, Lebrun M, Dubremetz JF, Bout D, Mevelec MN. Ismael AB, et al. Among authors: mevelec mn. J Infect Dis. 2006 Oct 15;194(8):1176-83. doi: 10.1086/507706. Epub 2006 Sep 11. J Infect Dis. 2006. PMID: 16991094

10

Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.

Hedhli D, Dimier-Poisson I, Judge JW, Rosenberg B, Mévélec MN. Hedhli D, et al. Among authors: mevelec mn. Vaccine. 2009 Apr 6;27(16):2274-81. doi: 10.1016/j.vaccine.2009.01.100. Epub 2009 Jan 31. Vaccine. 2009. PMID: 19428842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters